C4 Therapeutics, Inc.: cashflow_operating
| Value | {"amount": -47225000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-09-30 |
| Status | current |
| Entity | C4 Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bc1110e4-a09c-4588-8b6d-f1e3d5fc68c5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-044411Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001662579/cashflow-operating/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bc1110e4-a09c-4588-8b6d-f1e3d5fc68c5
History
- no predecessors — first report